Marković Iva, Wolfrum Therese, Wohlmann Andreas, Gautam Kritan, Friedrich Karlheinz
Institute of Biochemistry II, University Hospital Jena, Nonnenplan 2-4, D-07743 Jena, Germany.
Biol Chem. 2021 Oct 26;403(2):243-249. doi: 10.1515/hsz-2021-0293. Print 2022 Jan 27.
Thymic stromal lymphopoietin (TSLP) is a pro-inflammatory cytokine with important pathological roles in , malignant tumours and other diseases. The heterodimeric human TSLP receptor (hTSLPR) consists of the TSLP-binding subunit (TSLPRα) and the IL-7Rα-subunit. We studied the properties of hTSLP variants with mutations in their bipartite interaction interface towards IL-7Rα. One mutant (T46D/K101D) showed only mild impairment in receptor affinity but a massive reduction in biological activity. To facilitate the future development of hTSLP mutants with drug properties, we have devised a eukaryontic cytokine display assay with activity read-out and intrinsic genotype-phenotype coupling.
胸腺基质淋巴细胞生成素(TSLP)是一种促炎细胞因子,在恶性肿瘤和其他疾病中具有重要的病理作用。人TSLP受体(hTSLPR)异二聚体由TSLP结合亚基(TSLPRα)和IL-7Rα亚基组成。我们研究了hTSLP变体的特性,这些变体在其与IL-7Rα的二分相互作用界面中发生了突变。一种突变体(T46D/K101D)仅表现出受体亲和力的轻度受损,但生物活性大幅降低。为了促进具有药物特性的hTSLP突变体的未来开发,我们设计了一种具有活性读出和内在基因型-表型偶联的真核细胞因子展示测定法。